- Social Responsibility
- Social Responsibility
- Our Giving
- Corporate Social Responsibility
- Be The First Tobacco-Free Generation
- Health in Action Blog
- Thought Leadership
- Hiring Areas
- Why CVS
- Important Security Alert
- Investor Story
- Results Center
- 2016 In Review
- Financial Information
- SEC Filings
- Events & Presentations
- Stock Information
- Corporate Governance
- Investor Resources
CVS/pharmacy to Remove OTC Infant Cough & Cold Products from Its Stores as Part of CHPA's Voluntary Withdrawal
Thursday, October 11, 2007
WOONSOCKET, R.I., Oct. 11 /PRNewswire/ -- CVS/pharmacy, the retail division of CVS Caremark Corporation (NYSE: CVS), announced today that it is removing oral over-the-counter (OTC) infant cough & cold medicines from its stores as part of the Consumer Healthcare Products Association's (CHPA) voluntary withdrawal of these products.
Over-the-counter children's cough and cold medicine is safe and effective when used as directed. CHPA has announced the voluntary withdrawal of oral OTC infant cough and cold products due to rare instances of misuse leading to overdose, particularly involving infants under the age of two.
Effective immediately, CVS/pharmacy will remove from its stores all products subject to this voluntary withdrawal, as well as any CVS/pharmacy Brand equivalents. A block is being placed in our point-of-sale system to prevent sales of these items and all affected product is being removed from our store shelves. Customers who purchased any of these products at CVS/pharmacy may return them for a full refund.
Customers should discuss with their CVS pharmacist or their children's pediatrician alternative methods that are available for treating cough and cold symptoms in children under the age of two.
"The health and safety of our customers and their children is our highest priority," said Mike Bloom, Senior Vice President of Merchandising at CVS/pharmacy. "We support this voluntary action because CHPA is dedicated to ensuring the safety of healthcare products on the market and their members are some of our most trusted suppliers."
The voluntary product withdrawal does not affect infant and children's pain relievers, single-ingredient analgesics and nasal spray, drops or rubs for infants, or cough and cold medicines for children ages two and above.
For a complete list of products being voluntarily withdrawn or for more information about the withdrawal, please visit http://www.otcsafety.org .